Pfizer profit down 12% as sales of off-patent drugs fall
Net income attributable to shareholders fell to $3.40 billion, or 61 cents per share, in the quarter, from $3.88 billion, or 68 cents per share, a year earlier.
Trending Photos
![Pfizer profit down 12% as sales of off-patent drugs fall Pfizer profit down 12% as sales of off-patent drugs fall](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2020/04/28/857567-pfizerdeal.jpg?im=Resize=(400))
Pfizer Inc reported a 12.4% drop in first-quarter profit on Tuesday, partly hurt by a drop in sales its off-patent pain treatment Lyrica.
Net income attributable to shareholders fell to $3.40 billion, or 61 cents per share, in the quarter, from $3.88 billion, or 68 cents per share, a year earlier.
Revenue at the company, which is set to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV, fell 8.3% to $12.03 billion.
Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.
Live Tv